These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29407535)

  • 21. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
    Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
    Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.
    Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):625-632. PubMed ID: 28579072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of augmentation agents for treating depression: analysis of a psychiatric electronic medical record data set.
    Gersing KR; Sheehan JJ; Burchett B; Zhu L; Bates JA; Baker RA; Kalsekar ID
    Psychiatr Serv; 2014 Aug; 65(8):1062-5. PubMed ID: 24932958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
    Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
    Wu CS; Wang SC; Yeh IJ; Liu SK
    J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription patterns of Chinese herbal products for patients with sleep disorder and major depressive disorder in Taiwan.
    Chen YL; Lee CY; Huang KH; Kuan YH; Chen M
    J Ethnopharmacol; 2015 Aug; 171():307-16. PubMed ID: 26068429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of new second generation antipsychotics for major depressive disorder.
    McElroy SL; Guerdjikova A; Mori N; Keck PE
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1527-44. PubMed ID: 21105856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelines.
    Simons P; Cosgrove L; Shaughnessy AF; Bursztajn H
    Int J Law Psychiatry; 2017; 55():64-71. PubMed ID: 29157513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS; Chung CH; Gau CS
    J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential prevalence and demographic and clinical correlates of second-generation antipsychotic use in bipolar I versus bipolar II disorder.
    Park DY; Goffin KC; Shah S; Yuen LD; Holtzman JN; Hooshmand F; Miller S; Wang PW; Ketter TA
    J Psychiatr Res; 2016 May; 76():52-8. PubMed ID: 26874463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.
    Wu CS; Wang SC; Liu SK
    Bipolar Disord; 2015 Jun; 17(4):415-23. PubMed ID: 25295837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of chronic liver disease in patients with major depressive disorder: A population-based study.
    Hsu JH; Chien IC; Lin CH
    J Affect Disord; 2019 May; 251():180-185. PubMed ID: 30927578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS
    Int Clin Psychopharmacol; 2014 Mar; 29(2):116-9. PubMed ID: 24108149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MM; Fabbri C; Serretti A; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
    J Affect Disord; 2022 Jan; 296():485-492. PubMed ID: 34653701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.